Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2025-12-26 @ 2:58 AM
Study NCT ID:
NCT01290302
Status:
COMPLETED
Last Update Posted:
2025-06-12
First Post:
2011-01-10
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Blinded Cross-Over Bioequivalence (BE) Trial of Luitpold Azacitidine vs Vidaza
Sponsor:
American Regent, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11-22
Start Date Type:
ACTUAL
Primary Completion Date:
2012-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12-21
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-10
First Submit QC Date:
None
Study First Post Date:
2011-02-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2024-11-07
Results First Submit QC Date:
None
Results First Post Date:
2025-05-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-27
Last Update Post Date:
2025-06-12
Last Update Post Date Type:
ACTUAL